CVS Health Corp.SEC Filings
|
|
All SEC filings by CVS Health Corp. (CVS) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Aug 5, 2026 | |
| 10-Q | Quarterly report | View Diff | May 6, 2026 | |
| ARS | Annual report to shareholders | Apr 3, 2026 | ||
| 10-K | Annual report | View Diff | Feb 10, 2026 | |
| 10-Q | Quarterly report | View Diff | Oct 29, 2025 | |
| 10-Q | Quarterly report | View Diff | Jul 31, 2025 | |
| 10-Q | Quarterly report | View Diff | May 1, 2025 | |
| ARS | Annual report to shareholders | Apr 4, 2025 | ||
| 10-K | Annual report | View Diff | Feb 12, 2025 | |
| 10-Q | Quarterly report | View Diff | Nov 6, 2024 |
Events
| 8-K | Cvs Health Announces Board Changes | Aug 17, 2026 | ||
| 8-K | Results of Operations and Financial Condition | Aug 5, 2026 | ||
| 8-K | Departure of Directors or Certain Officers | May 18, 2026 | ||
| 8-K | Cvs Health Corporation Reports Strong First Quarter 2026 Results | May 6, 2026 | ||
| 8-K | Departure of Directors or Certain Officers | Mar 19, 2026 | ||
| 8-K | Results of Operations and Financial Condition | Feb 10, 2026 | ||
| 8-K | Regulation Fd Disclosure | Dec 9, 2025 | ||
| 8-K | Other Events | Nov 20, 2025 | ||
| 8-K | Cvs Health Corporation Reports Third Quarter 2025 Results and Updates Full-Year 2025 Guidance | Oct 29, 2025 | ||
| 8-K | Other Events | Sep 22, 2025 |
Registrations and Prospectuses
| S-8 | Registration of securities for employees | May 22, 2026 | ||
| S-3ASR | Automatic shelf registration | May 22, 2026 | ||
| 424B2 | Prospectus for primary offering | Aug 12, 2025 | ||
| FWP | Free writing prospectus | Aug 11, 2025 | ||
| FWP | Free writing prospectus | Aug 11, 2025 | ||
| 424B3 | Prospectus supplement | Aug 11, 2025 | ||
| 424B2 | Prospectus for primary offering | Dec 5, 2024 | ||
| FWP | Free writing prospectus | Dec 3, 2024 | ||
| 424B3 | Prospectus supplement | Dec 3, 2024 | ||
| S-8 | Registration of securities for employees | May 22, 2024 |
Proxies
| DEFA14A | Annual Meeting of Shareholders | Apr 3, 2026 | ||
| DEF 14A | Letter to Shareholders | View Diff | Apr 3, 2026 | |
| DEFA14A | Additional proxy soliciting materials | Apr 4, 2025 | ||
| DEF 14A | Annual Meeting of Shareholders | View Diff | Apr 4, 2025 | |
| PX14A6G | Letter to shareholders | Apr 16, 2024 | ||
| DEFA14A | Additional proxy soliciting materials | Apr 5, 2024 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 5, 2024 | |
| PX14A6G | Letter to shareholders | May 3, 2023 | ||
| PX14A6G | Letter to shareholders | Apr 26, 2023 | ||
| DEFA14A | Additional proxy soliciting materials | Apr 7, 2023 |
Other
| UPLOAD | Letter from SEC | Nov 21, 2024 | ||
| CORRESP | Correspondence with SEC | Nov 21, 2024 | ||
| UPLOAD | Letter from SEC | Nov 19, 2024 | ||
| CORRESP | Correspondence with SEC | May 15, 2023 | ||
| UPLOAD | Letter from SEC | May 15, 2023 | ||
| UPLOAD | Letter from SEC | May 11, 2023 | ||
| UPLOAD | Letter from SEC | Aug 27, 2019 | ||
| CORRESP | Correspondence with SEC | Aug 20, 2019 | ||
| UPLOAD | Letter from SEC | Aug 8, 2019 | ||
| CORRESP | Correspondence with SEC | Jul 10, 2019 |
Ownership
| SC 13G/A | Dodge & Cox Updates 3.9% Stake in Cvs Health Corp | Aug 13, 2026 | ||
| 13F-HR | Quarterly holdings report by institutional manager | Aug 6, 2026 | ||
| 4 | Clark James David | Jun 29, 2026 | ||
| 11-K | Annual report of employee stock purchases | Jun 23, 2026 | ||
| 4 | Newman Brian | Jun 1, 2026 | ||
| 4 | Compton-Phillips Amy | Jun 1, 2026 | ||
| 4 | Aguirre Fernando | May 22, 2026 | ||
| 144 | Notice of proposed sale of securities | May 22, 2026 | ||
| 4 | Robbins Larry | May 21, 2026 | ||
| 144 | Notice of proposed sale of securities | May 21, 2026 |